HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC label reform comments focus on 6-point type, "ask your pharmacist" labeling.

This article was originally published in The Rose Sheet

Executive Summary

OTC LABEL REFORM PROPOSAL COMMENT DEADLINE EXTENDED BY FDA for 100 days, from June 27 to Oct. 6. The extension responds to requests for more time from the Cosmetic, Toiletry and Fragrance Association and the Nonprescription Drug Manufacturers Association. CTFA requested a 120-day extension while NDMA asked for 90 days. FDA informed the associations about the extension in letters issued May 22.
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS004218

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel